Citations

1. Miller ST, et al. (2000). Prediction of adverse outcomes in children with sickle cell disease. New England Journal of Medicine, 342(2): 83–89.

2. Gladwin MT, et al. (2004). Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. New England Journal of Medicine, 350(9): 886–95.

3. Ballas SK (2001). Sickle cell disease: Current clinical management. Seminars in Hematology, 30(4): 307–314.

4. Hirst C, Wang W (2006). Blood transfusion for preventing stroke in people with sickle cell disease. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

5. National Heart, Lung, and Blood Institute, National Institutes of Health (2002). The Management of Sickle Cell Disease (NIH Publication No. 02-2117). Available online: http://www.nhlbi.nih.gov/health/prof/blood/sickle/.

6. Minter KR, Gladwin MT (2001). Pulmonary complications of sickle cell anemia. American Journal of Respiratory and Critical Care Medicine, 164(11): 2016–2019.

7. Wethers DL (2000). Sickle cell disease in childhood: Part I. Laboratory diagnosis, pathophysiology, and health maintenance. American Family Physician, 62(5): 1013–1020.

8. Wang WC (2004). Sickle cell anemia and other sickling syndromes. In JP Greer et al., eds., Wintrobe's Clinical Hematology, 11th ed., pp. 1264–1311. Philadelphia: Lippincott Williams and Wilkins.

9. Committee on Genetics, American Academy of Pediatrics (2002). Health supervision for children with sickle cell disease. Pediatrics, 109(3): 526–535.

10. Hirst C, Owusu-Ofori S (2006). Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

11. Goldstein LB, et al. (2006). Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke, 37(6): 1583–1633.

12. Davies S, et al. (2006). Hydroxyurea for sickle cell disease. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

13. Buchanan GR, et al. (2004). Sickle cell disease. Hematology (American Society of Hematology Education Program): 35–47.

Other Works Consulted

• Furie B, et al. (2003). Red blood cell disorders. In Clinical Hematology and Oncology: Presentation, Diagnosis, and Treatment, pp. 464–465. Philadelphia: Churchill Livingstone.

• Hillman RS, et al. (2005). Hemoglobinopathies. In Hematology in Clinical Practice, 4th ed., pp. 80–94. New York: McGraw-Hill.

• Meremikwu MM (2006). Sickle cell disease, search date August 2005. Online version of Clinical Evidence (15): 1–15.

• Schrier SL (2004). Hemoglobinopathies and hemolytic anemias. In DC Dale, DD Federman, eds., Scientific American Medicine, section 5, chap. 4. New York: WebMD.